Your English writing platform
Discover LudwigExact(8)
A 12 months follow up was used to determine whether MCI subjects converted to AD (MCI converters) or remained clinically stable (stable MCI).
Forty-seven per cent of PIB-positive subjects converted within 1 year, and these early converters showed higher tracer retention in the anterior cingulate and frontal cortex than late converters.
At longitudinal follow up of up to 3.5 years (mean 2.5±0.79 years), 11 MCI subjects converted to AD.
Among CN, 14 subjects converted to MCI and 2 to AD.
Only 1 of 14 (7%) amyloid-negative subjects converted in the same time period.
Thus, a questionable interpretation of data from patients with CKD and the subsequent extrapolation to healthy subjects converted a hypothesis into nutritional recommendations for the prevention of osteoporosis.
Similar(52)
11 However, not all MCI subjects convert to AD and therefore predicting converters would be useful for the clinician and for the patient and their carers.
Note that our converter group differs from these studies because we include only subjects converting after 1 year, whereas the other studies include any subjects converting from baseline.
Our findings indicate that this discrepancy is unlikely to be due to a large proportion of subjects converting to autoantibody positivity in later disease.
Viral surveillance showed a low percentage of subjects converting from normal test results at baseline to abnormal results post MEDI-546 administration: 4/31 subjects (12.9%) for EBV and 2/24 subjects (8.3%) for HPV.
As shown in Fig. 4, with increasing of risk alleles, the prevalence of subjects converting from IGT to NGT decreased significantly, and the prevalence of subjects remaining IGT or progressing to T2D increased significantly.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com